Rezolute, Inc. (RZLT) Dividend History

Rezolute, Inc. (RZLT) is a biotechnology company focused on developing treatments for metabolic and rare diseases. The company's portfolio includes therapies aimed at addressing diabetes, congenital hyperinsulinism, and other underserved conditions. Rezolute specializes in innovative drug formulations and has a pipeline of product candidates progressing through clinical development.

275 Shoreline Drive, Suite 500, Redwood City, CA, 94065
Phone: 650-206-4507
Website: https://www.rezolutebio.com

Dividend History

Rezolute, Inc. currently does not pay dividends

Company News

  • Rezolute Announces Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement

    Additional $6.7M in funding resulting in approximately $67M in gross proceeds Additional $6.7M in funding resulting in approximately $67M in gross proceeds

    GlobeNewswire Inc.
  • CommScope Holding And 2 Other Stocks Under $3 Insiders Are Buying

    The Dow Jones index closed higher by around 0.1% on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Agrify The Trade: Agrify Corporation (NASDAQ: AGFY) Chairman and CEO Raymond Nobu Chang acquired a total of 1,842,104 shares an average price of $0.38. To acquire these shares, it cost ...

    Benzinga
    Featured Companies: AGFY COMM
  • Rezolute, Inc. (RZLT) Upgraded to Buy: Here's Why

    Rezolute, Inc. (RZLT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

    Zacks Investment Research
Page data last updated 07/23/2025 20:15:26 UTC